Cargando…

Adoptive TIL in HPV-negative oral scca

Detalles Bibliográficos
Autores principales:	Leidner, Rom, Curti, Brendan D, Payne, Roxanne M, Urba, Walter, Bahjat, Keith S, Koguchi, Yoshinobu, Nelson, Krista, Moore, Jennifer A, Crittenden, Marka, Ying, Yedeh, Patel, Ashish, Cheng, Allen, Bui, Tuan G, Hilton, Traci, Paustian, Christopher, Puri, Sachin, Hu, Hong Ming, Bifulco, Carlo, Feng, Zipei, Bell, R Bryan, Fox, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645419/ http://dx.doi.org/10.1186/2051-1426-3-S2-P26

Ejemplares similares

An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers
por: Mougdil, Tarsem, et al.
Publicado: (2015)

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies
por: Moudgil, Tarsem, et al.
Publicado: (2014)

Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013)

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab
por: Koguchi, Yoshinobu, et al.
Publicado: (2015)

Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance
por: Couey, Marcus A., et al.
Publicado: (2019)

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
por: Sanborn, Rachel, et al.
Publicado: (2015)

Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer
por: Curti, Brendan D, et al.
Publicado: (2015)

Radiation and immunotherapy: Renewed allies in the war on cancer
por: Seung, Steven K., et al.
Publicado: (2012)

Novel strategy to monitor apparent tumor-specific T cells in patients with cancer
por: van de Ven, Rieneke, et al.
Publicado: (2013)

Evaluation of circulating tumor cell gene expression profiles before and following combination immunotherapy for advanced prostate cancer
por: Puri, Sachin, et al.
Publicado: (2014)

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
por: Feng, Zipei, et al.
Publicado: (2015)

Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer
por: van de Ven, Rieneke, et al.
Publicado: (2018)

Differential effects of periopathogens on host protease inhibitors SLPI, elafin, SCCA1, and SCCA2
por: Yin, Lei, et al.
Publicado: (2010)

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
por: Duhen, Rebekka, et al.
Publicado: (2021)

Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma
por: Curti, Brendan, et al.
Publicado: (2020)

Salivary Scca1, Scca2 and Trop2 in Oral Cancer Patients—A Cross-Sectional Pilot Study
por: Karmelić, Ivana, et al.
Publicado: (2022)

OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma
por: Montler, Ryan, et al.
Publicado: (2014)

Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients
por: Feng, Zipei, et al.
Publicado: (2014)

Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment
por: Andtbacka, Robert HI, et al.
Publicado: (2015)

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma
por: Leidner, Rom, et al.
Publicado: (2021)

Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease
por: Baird, Jason R., et al.
Publicado: (2018)

Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies
por: Fox, Bernard A., et al.
Publicado: (2023)

Metabolomics and lipid profile analysis of Coccomyxa melkonianii SCCA 048
por: Fais, Giacomo, et al.
Publicado: (2021)

Comparison of proteomic and genomic analyses of vaccine cell lines shows men receiving prostate gvax immunotherapy develop increased humoral responses to common cell line proteins relative to mutated proteins
por: Hulett, Tyler, et al.
Publicado: (2014)

Assessment of the tumor immune-environment in patients with head and neck cancer
por: Feng, Zipei, et al.
Publicado: (2015)

Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas
por: Crittenden, Marka, et al.
Publicado: (2015)

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
por: Sanborn, Rachel E., et al.
Publicado: (2017)

Radiation therapy and vaccination against tumor-specific EGFRvIII effectively clears tumors in a murine model of head and neck squamous cell carcinoma
por: Uhde, Lauren, et al.
Publicado: (2015)

A scalable platform for clinical immunophenotyping: assay design and quality control for high complexity flow cytometry
por: Koguchi, Yoshinobu, et al.
Publicado: (2015)

Explant Modeling of the Immune Environment of Head and Neck Cancer
por: Sharon, Shay, et al.
Publicado: (2021)

Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
por: Koguchi, Yoshinobu, et al.
Publicado: (2021)

Elevated Expression of Squamous Cell Carcinoma Antigen (SCCA) Is Associated with Human Breast Carcinoma
por: Catanzaro, Joseph M., et al.
Publicado: (2011)

Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production
por: Alice, Alejandro F., et al.
Publicado: (2021)

Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells
por: Ye, Wei, et al.
Publicado: (2014)

Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC
por: Trerotoli, Paolo, et al.
Publicado: (2009)

Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer
por: Qu, Tao, et al.
Publicado: (2019)

Fysikkpris til Fanamann
Publicado: (1981)

Petabytes til folket
Publicado: (2005)

Goldilocks and the three TILs
por: Dada, Hannah, et al.
Publicado: (2022)

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection
por: Sharon, Shay, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qqhk3vt6egvuo0pimi3ps0khv0